Literature DB >> 29753495

Global Prevalence of Presbyopia and Vision Impairment from Uncorrected Presbyopia: Systematic Review, Meta-analysis, and Modelling.

Timothy R Fricke1, Nina Tahhan2, Serge Resnikoff2, Eric Papas2, Anthea Burnett2, Suit May Ho3, Thomas Naduvilath3, Kovin S Naidoo4.   

Abstract

TOPIC: Presbyopia prevalence and spectacle-correction coverage were estimated by systematic review and meta-analysis of epidemiologic evidence, then modeled to expand to country, region, and global estimates. CLINICAL RELEVANCE: Understanding presbyopia epidemiologic factors and correction coverage is critical to overcoming the burden of vision impairment (VI) from uncorrected presbyopia.
METHODS: We performed systematic reviews of presbyopia prevalence and spectacle-correction coverage. Accepted presbyopia prevalence data were gathered into 5-year age groups from 0 to 90 years or older and meta-analyzed within World Health Organization global burden of disease regions. We developed a model based on amplitude of accommodation adjusted for myopia rates to match the regionally meta-analyzed presbyopia prevalence. Presbyopia spectacle-correction coverage was analyzed against country-level variables from the year of data collection; variation in correction coverage was described best by a model based on the Human Development Index, Gini coefficient, and health expenditure, with adjustments for age and urbanization. We used the models to estimate presbyopia prevalence and spectacle-correction coverage in each age group in urban and rural areas of every country in the world, and combined with population data to estimate the number of people with near VI.
RESULTS: We estimate there were 1.8 billion people (prevalence, 25%; 95% confidence interval [CI], 1.7-2.0 billion [23%-27%]) globally with presbyopia in 2015, 826 million (95% CI, 686-960 million) of whom had near VI because they had no, or inadequate, vision correction. Global unmet need for presbyopia correction in 2015 is estimated to be 45% (95% CI, 41%-49%). People with presbyopia are more likely to have adequate optical correction if they live in an urban area of a more developed country with higher health expenditure and lower inequality.
CONCLUSIONS: There is a significant burden of VI from uncorrected presbyopia, with the greatest burden in rural areas of low-resource countries.
Copyright © 2018 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29753495     DOI: 10.1016/j.ophtha.2018.04.013

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  65 in total

1.  Aldose reductase inhibition enhances lens regeneration in mice.

Authors:  Leonid M Zukin; Michelle G Pedler; Kevin Chyung; Sarah Seiwald; Patricia Lenhart; Biehuoy Shieh; J Mark Petrash
Journal:  Chem Biol Interact       Date:  2019-04-23       Impact factor: 5.192

2.  Monovision and the Misperception of Motion.

Authors:  Johannes Burge; Victor Rodriguez-Lopez; Carlos Dorronsoro
Journal:  Curr Biol       Date:  2019-07-25       Impact factor: 10.834

3.  Near Vision Spectacle Coverage and Associated Factors Among Adults Living in Finote Selam Town, Northwest Ethiopia: Community-Based Cross-Sectional Study.

Authors:  Sofonias Fekadu; Abel Assem; Yitayeh Mengistu
Journal:  Clin Ophthalmol       Date:  2020-10-07

4.  Automated detection of diabetic retinopathy in fundus images using fused features.

Authors:  Iqra Bibi; Junaid Mir; Gulistan Raja
Journal:  Phys Eng Sci Med       Date:  2020-09-21

5.  Do You See What Eye See? Measurement, Correlates, and Functional Associations of Objective and Self-Reported Vision Impairment in Aging South Africans.

Authors:  Meagan T Farrell; Yusheng Jia; Lisa F Berkman; Ryan G Wagner
Journal:  J Aging Health       Date:  2021-05-24

6.  EyeDiseases: an integrated resource for dedicating to genetic variants, gene expression and epigenetic factors of human eye diseases.

Authors:  Jian Yuan; Fukun Chen; Dandan Fan; Qi Jiang; Zhengbo Xue; Ji Zhang; Xiangyi Yu; Kai Li; Jia Qu; Jianzhong Su
Journal:  NAR Genom Bioinform       Date:  2021-06-01

7.  Improvement in Near Vision Following Silodosin Treatment in Patients With Lower Urinary Tract Symptoms.

Authors:  Hyun Jin Shin; Woo Suk Choi; Shin-Hyo Lee; Andrew G Lee; Aram Kim; Hyoung Keun Park; Sung Hyun Paick; Hyeong Gon Kim
Journal:  Int Neurourol J       Date:  2021-01-19       Impact factor: 2.835

8.  Spectacle Independence for Pseudophakic Patients - Experience with a Trifocal Supplementary Add-on Intraocular Lens.

Authors:  Carlos Palomino-Bautista; Rubén Sánchez-Jean; David Carmona Gonzalez; Marta Romero Domínguez; Alfredo Castillo Gómez
Journal:  Clin Ophthalmol       Date:  2020-04-09

Review 9.  Presbyopia - A Review of Current Treatment Options and Emerging Therapies.

Authors:  James A Katz; Paul M Karpecki; Alexandra Dorca; Sima Chiva-Razavi; Heather Floyd; Elizabeth Barnes; Mark Wuttke; Eric Donnenfeld
Journal:  Clin Ophthalmol       Date:  2021-05-24

Review 10.  Eye disease and mortality, cognition, disease, and modifiable risk factors: an umbrella review of meta-analyses of observational studies.

Authors:  Mike Trott; Lee Smith; Nicola Veronese; Damiano Pizzol; Yvonne Barnett; Trish Gorely; Shahina Pardhan
Journal:  Eye (Lond)       Date:  2021-07-16       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.